论文部分内容阅读
我们使用大分子硷性磷酸酶免疫试剂盒、对243例肝癌患者血清中大分子硷性磷酶同工酶(HMAP)含量、无选择的、分期分批地进行了体外诊断试验检测,并与目前临床使用的甲胎球蛋白(AFP)免疫测定进行了对比。结果表明:对肝癌的诊断敏感性高、特异性好、具有一定可靠性、重复性。与AFP检测形成多项互补的新手段,亦弥补了肝AFP测定不足之外。本试剂盒是一项比较敏感的用于肿瘤血清标志物免疫测定的新产品
We used macromolecular alkaline phosphatase immunoassay kits to perform in vitro diagnostic tests on haplo-phosphorous enzyme isoenzyme (HMAP) levels in the serum of 243 patients with hepatocellular carcinoma, without selection, and in batches. The current clinical use of alpha fetoprotein (AFP) immunoassay is compared. The results showed that the diagnosis of liver cancer has high sensitivity, good specificity, certain reliability, and repeatability. The formation of a number of complementary new means with the AFP test also compensates for the inadequacy of the liver AFP assay. This kit is a new and sensitive product for immunoassay of tumor serum markers